Burns McClellan has extensive experience advising public and private life sciences companies as they attract new investors while maintaining visibility with existing investors, prepare to raise capital to finance their advancement and expansion, and manage comprehensive day-to-day investor relations programs.

Burns McClellan maintains an unparalleled network of leading members of the financial community, including institutional investors, long-term healthcare focused funds, sell-side analysts, investment bankers, venture capital funds and industry leaders. Our investor relations team’s experience encompasses buy-side, sell-side, investment banking, and in-house corporate investor relations backgrounds.

We take a highly-strategic approach in order to help our clients achieve their investor relations goals. Whether our clients are aiming to gain initial introductions to leading healthcare investors in preparation for a private financing, crossover round or IPO, diversify their current shareholder base to prepare for the next stage of growth, increase stock liquidity and trading volume or reposition their investment theses, we combine our strategic insights with flawless tactical execution to ensure success.

Private Companies

We partner with private companies to support them in various types of financings including private/crossover rounds as well as the preparation for and execution of successful IPOs. We provide strategic counsel to our clients throughout each step of the private financing and listing process, including:

• Venture Capital Financing
• Mezzanine Financing
• Access to VCs & institutional crossover investors
• Access to investment bankers and sell-side analysts
• Pre-IPO / IPO / Post-IPO
  • Traditional IPOs
  • Reverse mergers
  • Form 10

Comprehensive private company investor relations services include:

• Develop IR strategy based on corporate objectives, timelines and milestones
• Build investor communications infrastructure
• Create and test-run corporate presentations with speaker presentation training
• Identify and facilitate introductions to leading VCs, institutional investors or long-term hedge funds who may be able to participate in near-term financings
• Arrange non-deal roadshows with target investors across major U.S. geographies
• Make introductions to healthcare-focused investment bankers and sell-side analysts
• Coordinate participation in investment banking conferences
• Conduct industry and competitive research to inform communications materials and other projects
• Provide market intelligence on competitive landscape and financings
• Provide IPO process support including S-1 drafting
• Foster relationships and create visibility among both private and public healthcare investors

Public Companies

We partner with public companies to enhance communication with key stakeholders and increase awareness among broad classes of investors. Burns McClellan can function as our clients’ in-house investor relations department and interact with key members of management and other constituencies to achieve corporate objectives.

Comprehensive public company investor relations services include:

• Develop and implement IR strategy based on corporate objectives, timelines and milestones
• Refine company messages and positioning across all communication materials including corporate presentation and website
• Conduct industry research to develop communications and investor relations strategy
• Provide market intelligence on competitive landscape and financings
• Provide comprehensive investor targeting and engagement strategy
• Arrange non-deal road shows for management to maintain and build relationships with institutional investors
• Make additional introductions to investment bankers and sell-side analysts
• Coordinate and manage participation in investment banking conferences
• Run quarterly financial reporting processes, including script and Q&A development and managing logistics for investor conference calls and webcasts
• Produce relevant investor relations materials for Board of Directors meetings
• Manage the investor relations section of the Company’s website
• Develop and execute event-specific investor relations and communications strategies around major clinical and corporate milestone announcements
• Foster introductions to key opinion leaders (KOLs) from the biotech/pharma industry
• Actively coordinate opportunities for KOLs to assist in the investor education process, including with sell-side analysts
• Organize investor and analyst events at major scientific conferences
• Manage R&D Days, including content creation and logistical coordination